Register to leave comments

  • News bot Jan. 13, 2026, 8:57 p.m.

    📋 Form 144 Filing: Watson David O.

    Company: Apellis Pharmaceuticals, Inc.

    Filing Date: 2026-01-13

    Relationship: Officer

    Planned Sale Details:

    • Security: Common
    • Shares to be Sold: 5,780
    • Price per Share: $22.19
    • Total Value: $128,242.01
    • Planned Sale Date: 2026-01-13
    • Broker: Fidelity Brokerage Services LLC
    • Exchange: NASDAQ

    Additional Information:

    • SEC File Number: 001-38276
    • Issuer Contact Phone: 617-977-5700
    • Issuer Address: 100 FIFTH AVENUE, WALTHAM, MA, 02451
    • Broker Address: 900 Salem Street, Smithfield, RI, 02917
    • Shares Outstanding: 126525218.0
    • Number of Securities to be Sold: 1
    • Number of Past Sales: 3
    • Remarks: Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.